← Back to Search

Cannabinoid

THC for Cannabis Effects (THC-Gender Trial)

Phase 1
Recruiting
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 25 minutes after thc infusion begins
Awards & highlights

THC-Gender Trial Summary

This trial will study how men and women differ in their reaction to marijuana.

Who is the study for?
This trial is for people who have tried cannabis at least once and are in good physical and mental health. Women can't join if they're taking estrogen supplements or birth control pills, and it's not for anyone who has never used cannabis or those dealing with major stress recently.Check my eligibility
What is being tested?
The study is looking into how THC (the active component of cannabis) affects men and women differently when taken acutely. Participants will receive either THC or a placebo to compare the immediate effects between genders.See study design
What are the potential side effects?
THC may cause short-term side effects such as altered senses, changes in mood, impaired body movement, difficulty with thinking and problem-solving, impaired memory, hallucinations, delusions, or psychosis.

THC-Gender Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~25 minutes after thc infusion begins
This trial's timeline: 3 weeks for screening, Varies for treatment, and 25 minutes after thc infusion begins for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rewarding Effects measured by Visual Analog Scale (VAS)
Verbal Learning: measured by Rey Auditory Verbal Learning Test (AVLT)

THC-Gender Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: THCActive Control1 Intervention
Active THC (0.015mg/kg) administered intravenously over 10 minutes.
Group II: PlaceboPlacebo Group1 Intervention
Control: small amount of alcohol intravenously (quarter teaspoon), with no THC over 10 minutes.

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Yale UniversityLead Sponsor
1,841 Previous Clinical Trials
2,734,427 Total Patients Enrolled
14 Trials studying Cannabis
724 Patients Enrolled for Cannabis

Media Library

THC (Cannabinoid) Clinical Trial Eligibility Overview. Trial Name: NCT02781519 — Phase 1
Cannabis Research Study Groups: THC, Placebo
Cannabis Clinical Trial 2023: THC Highlights & Side Effects. Trial Name: NCT02781519 — Phase 1
THC (Cannabinoid) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02781519 — Phase 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research endeavor open to applicants above the age of 79?

"The age requirement for this research trial is between 18-55. For those outside of that range, there are 16 trials available for minors and 73 studies accessible to seniors."

Answered by AI

Are there other documented instances of scientific research into the effects of THC?

"At the moment, 38 medical trials involving THC are live with 6 of them in phase 3. 90 different sites across the nation provide this treatment but Belmont, Massachusetts hosts most of these investigations."

Answered by AI

Are there any regulatory sanctions that allow for the use of THC?

"The safety of THC is ranked a 1 on our risk index, as this trial is only in Phase 1 and there is limited evidence for both efficacy and security."

Answered by AI

Are there opportunities available to join this research initiative?

"Affirmative. According to information available on clinicaltrials.gov, registration for this trial opened up on June 1st 2015 and was recently updated in July of 2022. 100 participants need to be recruited from a single location for the study's completion."

Answered by AI

Do I qualify for participation in this research project?

"In order to be enrolled in this hashish abuse research project, potential patients need to fit the age range of 18-55. The study is looking for a total of one hundred participants."

Answered by AI

What clinical conditions does THC commonly treat?

"THC can assist patients with issues such as inadequate response to existing treatments, weight loss, and a lack of interest in food."

Answered by AI

How many participants are enrolled in this research endeavor?

"Confirmed. According to the clinicaltrials.gov website, this research study is actively enrolling patients and has been since June 1st 2015. The trial is seeking 100 participants from a single medical centre for evaluation."

Answered by AI
~2 spots leftby Jun 2024